J&J | JNJ - Trade Debtors


J&J reported $22.54B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Abbott USD 11.22B 655M Mar/2026
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Boston Scientific USD 2.93B 98M Dec/2025
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
CONMED USD 247.83M 22.89M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Globus Medical USD 735.44M 8.23M Mar/2026
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merck USD 11.78B 345M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026
Zoetis USD 1.51B 84M Mar/2026